DMD and Duchenne muscular dystrophy: Moreover, a new approach was proposed for cell-based therapy for Duchenne muscular dystrophy [11,12], which is based on the use of cells called muscle side population (SP) cells to deliver genes, such as the human micro-dystrophin, showing their capability in recapitulating the myogenic lineage.